Accelerator Life Science Partners

What they do

Founded in 2003, Accelerator Life Science Partners operates as a premier venture catalyst in the biotechnology sector. Rather than acting as a passive source of capital, ALSP employs a company-building model where they identify highly innovative, early-stage science-often spun out of leading academic institutions-and build companies around it. They provide a "complete toolkit" that includes committed investment capital, experienced start-up management, world-class scientific oversight, and state-of-the-art laboratory facilities. ALSP is highly regarded in the life sciences ecosystem for its strong syndicate of pharmaceutical corporate venture partners and its impressive track record of incubating companies that achieve major acquisitions.

What they look for

ALSP's mission is to catalyze the development and commercialization of breakthrough biotechnology innovations. They focus on early-stage life science technologies that have the potential to address critical problems and underserved medical needs, transforming novel ideas into impactful global health products.

Stage

Pre-seed, Seed, Series A, Series B+

Sectors

Healthcare, Deeptech

Based

Seattle, US